Innopeutics Corporation
Clinical trials sponsored by Innopeutics Corporation, explained in plain language.
-
Gene therapy for Parkinson's: will it last? new study tracks 6 patients over time
Disease control Recruiting nowThis study checks the long-term safety and lasting effects of a gene therapy called IPS101A in 6 people with severe Parkinson's disease who already received it in an earlier trial. Researchers will monitor side effects and measure changes in movement symptoms over time. The goal …
Sponsor: Innopeutics Corporation • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Gene therapy hope for severe Parkinson's patients
Disease control Recruiting nowThis early-stage trial tests a gene therapy called IPS101A in 6 people with advanced Parkinson's disease (stages 4-5) whose symptoms are not controlled by current medications. The main goal is to check safety and find the best dose. Researchers will also look for any signs that t…
Phase: PHASE1 • Sponsor: Innopeutics Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC